JEFFREY SLAVICH: Open Payments
NPI 1780694000 · POCATELLO, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,506 in 68 payments from 12 companies in 2025. Trend: 2023 $15 · 2024 $639 · 2025 $1,506
Food & beverage: $1,332Education: $174
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $407 |
| Janssen Biotech, Inc. | 12 | $353 |
| Amgen Inc. | 15 | $207 |
| GlaxoSmithKline, LLC. | 8 | $166 |
| ABBVIE INC. | 4 | $114 |
| Novartis Pharmaceuticals Corporation | 6 | $93 |
| Actelion Pharmaceuticals US, Inc. | 1 | $67 |
| ANI Pharmaceuticals, Inc. | 1 | $33 |
| Viatris Specialty LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
Products named: Bimzelx, TREMFYA, BENLYSTA, COSENTYX, KRYSTEXXA, OTEZLA, UPTRAVI, RINVOQ.
Industry payments across ID — which companies pay providers there.
